Table 3.
Changes in medication among patients taking insulin at baseline
| Participant | Week 0: Total daily dose | Week 24: Total daily dose |
| Low-glycemic, reduced-calorie diet group (total n = 29) | ||
| 1 | insulin 24 units | none |
| insulin sliding scale three times a day | none | |
| 2 | insulin 85 units | insulin 13 units |
| 3 | insulin 160 units | insulin 120 units |
| Low-carbohydrate, ketogenic diet group (total n = 21) | ||
| 1 | insulin 50 units | none |
| 2 | insulin 90 units | none |
| 3 | insulin 32 units | none |
| rosiglitizone 4 mg/metformin 2000 mg | metformin 1000 mg | |
| 4 | insulin 40 units | none |
| metformin 2000 mg | metformin 2000 mg | |
| 5 | insulin 40 units | insulin 35 units |
| insulin sliding scale three times a day | none | |
| 6 | insulin 120 units | insulin 90 units |
| metformin 2000 mg | metformin 2000 mg | |
| 7 | insulin 135 units | insulin 60 units |
| 8 | insulin 80 units | insulin 8 units |
| pioglitazone 45 mg | pioglitazone 45 mg | |
| glimiperide 8 mg | glimiperide 8 mg | |
*Medications were adjusted using a pre-specified algorithm based upon home and return visit blood capillary glucose measurements.